| |
| |
|
| Insider
Information: |
Socks David A |
| Relationship: |
Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
105,245 |
|
|
Indirect Shares
|
1,980,811 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$12,181,831 |
|
|
| Total
Shares |
2,086,056 |
|
|
| Total
Value |
$12,181,831 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cadence Pharmaceuticals Inc |
CADX |
SVP |
2010-06-14 |
96,245 |
|
0 |
Premium* |
|
|
Phathom Pharmaceuticals, Inc. |
PHAT |
Director |
2023-05-25 |
9,000 |
2023-05-25 |
1,211,756 |
Premium* |
|
|
Hillevax, Inc. |
HLVX |
Officer |
|
0 |
2022-04-28 |
769,055 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADX |
Cadence Pharmaceuticals I... |
VPOfficer |
• – – |
2006-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
212,500 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
VP |
• – – |
2008-02-20 |
4 |
A |
$5.34 |
$19,998 |
D/D |
3,745 |
216,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-07-13 |
4 |
AS |
$10.33 |
$129,115 |
D/D |
(12,500) |
203,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-08-10 |
4 |
AS |
$10.98 |
$137,278 |
D/D |
(12,500) |
191,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-09-14 |
4 |
AS |
$10.57 |
$133,610 |
D/D |
(12,500) |
178,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-10-12 |
4 |
AS |
$11.60 |
$145,033 |
D/D |
(12,500) |
166,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-11-09 |
4 |
AS |
$10.00 |
$125,055 |
D/D |
(12,500) |
153,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-12-14 |
4 |
AS |
$9.34 |
$93,427 |
D/D |
(10,000) |
143,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2009-12-17 |
4 |
AS |
$10.00 |
$25,000 |
D/D |
(2,500) |
141,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-01-04 |
4 |
OE |
$0.40 |
$10,000 |
D/D |
25,000 |
166,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-01-11 |
4 |
AS |
$10.06 |
$125,753 |
D/D |
(12,500) |
153,745 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-02-08 |
4 |
AS |
$10.26 |
$128,190 |
D/D |
(12,500) |
141,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-03-08 |
4 |
AS |
$9.30 |
$92,973 |
D/D |
(10,000) |
131,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-04-12 |
4 |
AS |
$9.31 |
$93,076 |
D/D |
(10,000) |
121,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-04-19 |
4 |
AS |
$10.00 |
$50,000 |
D/D |
(5,000) |
116,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-05-10 |
4 |
AS |
$9.20 |
$92,014 |
D/D |
(10,000) |
106,245 |
0 |
- |
|
| CADX |
Cadence Pharmaceuticals I... |
SVP |
• – – |
2010-06-14 |
4 |
AS |
$7.05 |
$70,500 |
D/D |
(10,000) |
96,245 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
President, CEO, Treas. & Sec.O |
• • – |
2019-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,686,704 |
|
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-11-09 |
4 |
AS |
$41.95 |
$456,506 |
I/I |
(10,784) |
1,676,562 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-11-10 |
4 |
AS |
$41.29 |
$528,672 |
I/I |
(12,681) |
1,659,480 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-11-11 |
4 |
AS |
$38.17 |
$268,021 |
I/I |
(6,877) |
1,652,603 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-12-16 |
4 |
AS |
$46.22 |
$1,494,519 |
I/I |
(31,446) |
1,621,157 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2020-12-17 |
4 |
AS |
$40.49 |
$1,964,376 |
I/I |
(48,212) |
1,572,945 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-01-11 |
4 |
AS |
$34.92 |
$448,243 |
I/I |
(12,835) |
1,560,110 |
0 |
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Director |
– • – |
2021-01-12 |
4 |
AS |
$35.74 |
$979,795 |
I/I |
(27,165) |
1,532,945 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
